François‐Xavier Dieudonné

Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice

François‐Xavier Dieudonné, Allison Marion, Pierre J. Marie et al. · Journal of Bone and Mineral Research · 2012 · 47 citations · Full text

Medicine, Cell Biology, Oncology +17

High Wnt Signaling Represses the Proapoptotic Proteoglycan <i>syndecan-2</i> in Osteosarcoma Cells

François‐Xavier Dieudonné, Allison Marion, Eric Haÿ et al. · Cancer Research · 2010 · 46 citations · Full text

Medicine, Cell Biology, Oncology +17

FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo

Julia Brun, François‐Xavier Dieudonné, Caroline Marty et al. · PLoS ONE · 2013 · 45 citations · Full text

Medicine, Molecular Biology, Oncology +16

Calpain‐6 is an endothelin‐1 signaling dependent protective factor in chemoresistant osteosarcoma

Allison Marion, François‐Xavier Dieudonné, Ana Patiño‐García et al. · International Journal of Cancer · 2011 · 35 citations · Full text

Life Sciences, Cell Biology, Oncology +17

The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b

Julia Brun, Olivia Fromigué, François‐Xavier Dieudonné et al. · Bone · 2012 · 33 citations

Medicine, Cell Biology, Molecular Genetics +15